AAVXF

Quote

Short

News

Articles

Message Board

Abivax (OTCMKTS : AAVXF ) News

Abivax (OTCMKTS: AAVXF) News Releases

AAVXF News Releases

June 02, 2026 01:33:24 pm

SeekingAlpha

Abivax: Downgrading To 'Hold' As NDA Obefazimod Still Underway Despite Major Safety Risks

June 02, 2026 09:51:51 am

SeekingAlpha

ABIVAX Société Anonyme (ABVX) Discusses Positive Phase III ABTECT Trial Results for Obefazimod in Ulcerative Colitis Transcript

June 01, 2026 04:05:00 pm

GlobeNewswire

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

May 22, 2026 04:05:00 pm

GlobeNewswire

Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis

May 11, 2026 04:05:00 pm

GlobeNewswire

Abivax Announces Results of its May 11, 2026 Annual General Meeting

May 05, 2026 02:00:00 am

GlobeNewswire

Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (Euro38.5M) Offering of American Depositary Shares

April 22, 2026 04:05:00 pm

GlobeNewswire

Abivax to Present Data on Obefazimod at Digestive Disease Week®

April 20, 2026 04:05:00 pm

GlobeNewswire

Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents

April 01, 2026 04:05:00 pm

GlobeNewswire

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies

April 01, 2026 11:00:30 am

SeekingAlpha

Abivax: Obefazimod's Strategic Scarcity Drives Optionality (Maintaining Buy)

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account